Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
J Virol. 2024 Jul 23;98(7):e0202023. doi: 10.1128/jvi.02020-23. Epub 2024 Jun 17.
Human noroviruses (HuNoVs) are a diverse group of RNA viruses that cause endemic and pandemic acute viral gastroenteritis. Previously, we reported that many HuNoV strains require bile or bile acid (BA) to infect human jejunal intestinal enteroid cultures. BA was not essential for the replication of a pandemic-causing GII.4 HuNoV strain. We found the hydrophobic BA glycochenodeoxycholic acid (GCDCA) promotes the replication of the BA-dependent strain GII.3 in jejunal enteroids. Furthermore, we found that inhibition of the G-protein-coupled BA receptor, sphingosine-1-phosphate receptor 2 (S1PR2), by JTE-013, reduced GII.3 infection dose-dependently and inhibited GII.3 cellular uptake in enteroids. Herein, we sought to determine whether S1PR2 is required for other BA-dependent HuNoV strains, the BA-independent GII.4, and whether S1PR2 is required for BA-dependent HuNoV infection in HIEs from other small intestinal segments. We found a second S1PR2 inhibitor, GLPG2938, reduces GII.3 infection dose-dependently, and an S1PR2 agonist (CYM-5520) enhances GII.3 replication in the absence of GCDCA. GII.3 replication also is abrogated in the presence of JTE-013 and CYM-5520. JTE-013 inhibition of S1PR2 in jejunal HIEs reduces GI.1, GII.3, and GII.17 (BA-dependent) but not GII.4 Sydney (BA-independent) infection, providing additional evidence of strain-specific differences in HuNoV infection. Finally, GII.3 infection of duodenal, jejunal, and ileal lines derived from the same individual is reduced with S1PR2 inhibition, indicating a common mechanism of BA-dependent infection among multiple segments of the small intestine. Our results support a model where BA-dependent HuNoVs exploit BA effects on S1PR2 to infect the entire small intestine.IMPORTANCEHuman noroviruses (HuNoVs) are important viral human pathogens that cause both outbreaks and sporadic gastroenteritis. These viruses are diverse, and many strains are capable of infecting humans. Our previous studies have identified strain-specific requirements for hydrophobic bile acids (BAs) to infect intestinal epithelial cells. Moreover, we identified a BA receptor, sphingosine-1-phosphate receptor 2 (S1PR2), required for infection by a BA-dependent strain. To better understand how various HuNoV strains enter and infect the small intestine and the role of S1PR2 in HuNoV infection, we evaluated infection by additional HuNoV strains using an expanded repertoire of intestinal enteroid cell lines. We found that multiple BA-dependent strains, but not a BA-independent strain, all require S1PR2 for infection. In addition, BA-dependent infection requires S1PR2 in multiple segments of the small intestine. Together, these results indicate that S1PR2 has value as a potential therapeutic target for BA-dependent HuNoV infection.
人诺如病毒(HuNoVs)是一组多样化的 RNA 病毒,可引起地方性和大流行急性病毒性肠胃炎。以前,我们报道过许多 HuNoV 株需要胆汁或胆汁酸(BA)来感染人空肠肠类器官培养物。BA 对引起大流行的 GII.4 HuNoV 株的复制不是必需的。我们发现疏水性 BA 甘氨胆酸(GCDCA)促进了依赖 BA 的 GII.3 株在空肠肠类器官中的复制。此外,我们发现,G 蛋白偶联 BA 受体,鞘氨醇-1-磷酸受体 2(S1PR2)的抑制剂 JTE-013 可剂量依赖性地降低 GII.3 感染,并抑制肠类器官中的 GII.3 细胞摄取。在此,我们试图确定 S1PR2 是否是其他依赖 BA 的 HuNoV 株、非依赖 BA 的 GII.4 株所必需的,以及 S1PR2 是否是依赖 BA 的 HuNoV 在来自其他小肠段的 HIEs 中的感染所必需的。我们发现第二种 S1PR2 抑制剂 GLPG2938 可剂量依赖性地降低 GII.3 感染,并且 S1PR2 激动剂(CYM-5520)在没有 GCDCA 的情况下增强 GII.3 复制。GII.3 复制也在 JTE-013 和 CYM-5520 的存在下被阻断。JTE-013 抑制空肠 HIEs 中的 S1PR2 可降低 GI.1、GII.3 和 GII.17(依赖 BA)但不降低 GII.4 Sydney(不依赖 BA)的感染,这为 HuNoV 感染中的株特异性差异提供了额外证据。最后,用 S1PR2 抑制剂抑制 S1PR2 可降低来自同一个体的十二指肠、空肠和回肠系的 GII.3 感染,表明在小肠的多个节段存在依赖 BA 的感染的共同机制。我们的结果支持了这样一种模型,即依赖 BA 的 HuNoVs 利用 BA 对 S1PR2 的作用来感染整个小肠。
意义:人诺如病毒(HuNoVs)是引起暴发和散发性肠胃炎的重要人类病毒病原体。这些病毒具有多样性,许多株能够感染人类。我们之前的研究已经确定了疏水性胆汁酸(BAs)对感染肠上皮细胞的株特异性要求。此外,我们确定了 BA 受体,鞘氨醇-1-磷酸受体 2(S1PR2),是依赖 BA 的株感染所必需的。为了更好地了解各种 HuNoV 株如何进入和感染小肠以及 S1PR2 在 HuNoV 感染中的作用,我们使用扩展的肠类器官细胞系评估了其他 HuNoV 株的感染。我们发现,多种依赖 BA 的株,而不是非依赖 BA 的株,都需要 S1PR2 进行感染。此外,BA 依赖的感染需要 S1PR2 在小肠的多个节段。这些结果表明,S1PR2 作为一种有价值的潜在治疗靶点,可用于治疗依赖 BA 的 HuNoV 感染。